News & Insights
Biofidelity Awarded £500,000 Innovate UK Grant
Biofidelity has received £500,000 in grant funding from Innovate UK to co-fund a 12-month project validating its platform for the sensitive detection of mutations used to treat non-small-cell lung cancer.
The funding will help the Company develop its platform chemistry for use in companion diagnostic tests, helping guide therapy while monitoring the acquisition of resistance.
Click here for the Company’s official press release.